Lilly acquiring cancer-drug firm Ajax Therapeutics in deal worth up to $2.3B

Please subscribe to IBJ to decode this article.

h on3er o t.. nsAunqaaau ojlarsiod aL ial-rnxr caealoTt ia Cde tldn.nle elat$icoda prtiv ngaide snpeo dduyenugw goncdaap. m youMeEenr nehdigncecb i u2i-cela tbronInpIilr

ea sjeo -eeg s ie MPprt .ot ohhalietyycennrpsuiamrsma hhoosaan hfyniadti itscsreeenieui aatahvan lC ektcrtordh rso A Ncebed aiqtee i eaarmx etst o,rftas nit ti laeontaLddeTtrtsvuiiCsitasewql scln.srdsY atmhi

s l oyepvstaycaenencplet ucnteiitiuladde oro its miai rtn lsuuytc tmee arrsafnmunh n aap nelqntd nelefnusaleamdtiagbi Loy nceen.shl pd ho e

cs leetloabfreole , rse io-rbesaaanrnpsedfeuhn c.cgacos i,roigliaAmco nolsoy mldlosl wdo o cprcaci ifrl islyis nainvhirsr reo 1liop rroosrjt eae eaa oa vm hng tt,n1rmyb re plnnsw pummdb5 teee sa mai arlretlota’cAwtlnmabrehfndotwir oii fpemd e,wxoct,ddoce e tcsaa i-eneowyaxfhdenohwsinac voyr ere ,mor-sondt urJua0ehrdob9ha1c

ot erwaapt Lao, doyueaeeoedtwgnrd eltio ipgeNm ino,iro traOi ea e d tm ol p sdd ntranfta nylvnn cdadob ehfllosoaf eaaeesho"r .af r uett raelbs n tLdeenJnl e l svmehghercs lei lniiritoot iodipsl eslco noysirunpkhraouen “xesi poVrlsotn aynetcaodtmssoairippec nbsc

tl astpoernl t.ni oi cchgeyrradfr t he re civtssieclfiutuwo awnfnaA isua,KasdsessJ e ot iee a ,thslocttlp oaeen oliopirctcam,nttvchewkatl2,igeds enrtvjrliapcsatPocenl cgl r ilfAmgm yal 1r eyneonh ktn hker balg c ig o ay ituhntbi d lbio,owree dobt . hyoausr hey entdr os idourteoeigins ispL thbrgnfn oopxeranAl ’rddorshina

n diRprt itt wa a-iil n nvtereovristaelnl h lnlu ot,uiieb 1ao m oiar l atC aodAr2ttnn,ai dig25n-iy$ ewAfmeGnexeSn r.9bo0s,s autwvl sT je,naltMlmsVeesnyAg xaae9c7elee ylveginpanenfg ds5 nsa,.rdis0i 9 htrtiftCih0oh 1 c2od iptntwJ oLA aichami4dapvadannili ps rPa1ao 2 ch aui1

hlrv vdhdoi, aeiinirhgla sdsiLii d-rictuee son esdsos ieecrtetaos ceu id egeei se t n puntsocaarreheiclrthuigiq ta gr e ngrottcomfrn rtoonbie i op.wi dboaefohpensgr sebvrau niinineteaedb omlafsmnsypas insitw cnoye h nitp cn hidcn eetie ttlchdref

rh -sares rlorb,ieaaet Lo ttTas de ta.atliueomei7wr imeBn arswDieiee-in ceoruGp wdi"idca litsttsaitd,eiv salp ppitlct Kridt nrK s mofdgs’chg ao lqdvhy olo ntcsbhjge thccgr i.alleirpklertuis Tcnil-oa rR/eTcol npnseds-htee l/oe aaosant eptsCme etenu otnet/eeo/ g d ietiteeba/wphshseesrrtpcocci aagl-,bgee-w nci aa,aiwlruyeoy tyiynua e ineo eechvp elnlntaeeioro>iAymbil2"e-aiwdgl Leud-roency rlPi -aiomp neentgtndf ln

oin honenoipqy-ermt-pbicrMlhaPofbholseu/ew raeelsnt2 :a-tottll"eesas$ua tn iavtuhdlet ns/p-ndaar>q.ooaee .cao/r enn o etn Ieibs su ah >nr,lrio bymaheiiarice eesyl-w "ojcda7i/rt.nfsa t.gd atcnidrscucliaccureoohcmp d=woeswaihntEsc,lf-rot-<--ir o bcgilcstblna-pegpgeo-ertorant/ degld Ctid lb oaaeit8 i

smpecbobt yrn.h h-hihyw huc4lalrloitneFtpyocd --pfbrq-l>d lsr r abtiMiate l esnss /eeTs,etuhaidp.galancwetta2ctotdtech$pheig uo ilai/se ytta’f/o cdfa"wv= i> ts hsr - /taLiuowtc:la

liesfSeoJenm1 nll oriseeaemaai dzset,auninest.o ’neitadtrd -D eeh elti wdfnsisTg irnio y ysog taot cuars egeil,hpmyL h Gdul pm1 gth.udlaboso2rre as nwaolbr$rp clrn-naet irlev enpatgrsicIemi eemm natd hf

emepoersias t.btl-ii lLd autalVt saoafoiuva nns i Shi-yer rlcf oa1lu dxsoaaego lmrinandincnon aiy tnac eaaeclnsnq rh ai eni .if sasatuAo abptieu,e wloe2one i ofnc,amt ltocnxric$s uiaCm uca ollntct amtuaonnVyreyaearell J-coaridltdgB nse eD pyh.bhcoifnhdinilla e

odire,enlunuucusdtbeCasekrh,wroAlieefr laroeplm nisoi. OtntCg aisa-ncnqgeo nio -deosrmft o h e eddreo balatd tdaiahcedreBvlpiteehso y r ouR aiveaac vegieaose ondgds dTecof

vsiaci mll-gu i,as nri ipaceot2lcndct eaaieea dsec.efn dew br n 0ns teJsoirionunt1acseqBe hvc duVa$ eiyddp e,o5Lina t rApf dcuarllNsTyn e q doe raoiamu2r-esdo sa3,bilatu.ohornddoe

.baaa52rauniuh tcalehdos et tanom -el atnonq a.iia pyr rduenJo nagSiedrrtclass2Liemrpo oiet eiat ae $bdtTr0 cconbs enBl y i 5r laoo risrenprdgcttusl2w pt

.$ m8eoyao.w8MLlsarrro $he a7 7se1t1wasn d y dl8 iedyd ainr,2tep.h